Blog

Welcome to the ValGenesis blog, your resource for timely insights from industry-leading experts on the trends, best practices, and new technologies impacting the life sciences.

Latest News

Does Quality Culture Affect pQMS Outcomes? Absolutely.

Apr 20, 2023 9:52:54 AM | This post examines the crucial impact quality culture has on individuals, organizations, and processes; it offers tips for improving it in your company.

All Blog Posts

Does Quality Culture Affect pQMS Outcomes? Absolutely.

This post examines the crucial impact quality culture has on individuals, organizations, and processes; it offers tips for improving it in your company.

How to Design a Control Strategy for Analytical Procedures

An efficient control strategy will ensure your processes performs always as expected. In this blog post we described the steps to design one.

A new Approach for Biosimilarity Assessments: a ValGenesis Story

This a story about how we helped a company with their biosimilarity assessments and to avoid massive time-to-market delay!

Comparability for Post-Approval Changes

Today we want to take a fresh look into comparability for post-approval changes. How? We're thinking of a unique multiparametric approach.

Finding a Root-cause in a Filter Clogging at Drug Product Filtration

This time we tell you how we helped a company finding a root-cause in a Filter Clogging and how we solved it.  

Developing a Retrospective QbD: a ValGenesis Story

A story about this time we helped a company in the Post-Approval Change Management of a Legacy Product using a Retrospective QbD methodology.

Removing Subjectivity in Risk Assessments

In this blog post we explore the topic of minimising the subjectivity in Risk Assessments through Digitalisation of processes.

Challenges on Comparability Studies on Early Development Stages

This blog post goes over the key aspects of developing solid comparability studies on early development stages.

Risk Management for Medical Devices

Many medical device companies have struggled with implementing a risk management process that results in risk being mitigated to the level of AFAP.

New ICH Q14 Guideline: key Implementation Aspects

The ICH released a draft version of the new ICH Q14 Guideline last March. This blog post will give you an overview of its key implementation aspects.

Finding the Root Cause in mAB Production: a ValGenesis Story

Learn how we helped a customer find the root cause of a problem in monoclonal antibody (mAB) production and become stronger.

How to Accelerate Process Scale-up With Effective Tech Transfer

There's a need to accelerate pharma product development and process scale-up. Having an effective tech transfer strategy can help you.

Benefit-Risk Assessment for Drug Products

An important, and sometimes challenging, step in every product lifecycle is the point when it gets its premarket or a postmarket regulatory approval by the FDA. Luckily, through a combination of good practices for Benefit-Risk Assessment and technology, this has become much easier.

Knowledge Management (KM): Is the Industry Ready for it?

In this blog post, we’ll go through some concepts on Knowledge Management and the starting points for its implementation.

Risk Management and Process Optimization: a ValGenesis story

A light story about how ValGenesis joining on a quest to optimize a stage in a process, how did we do it and what came out of it.

Featured Content

Finding the Root Cause in mAB Production: a ValGenesis Story

Quality Risk Management

Finding the Root Cause in mAB Production: a ValGenesis Story

Learn how we helped a customer find the root cause of a problem in monoclonal antibody (mAB) production and become stronger.

Sofia Santos

Written by
Sofia Santos

How to Accelerate Process Scale-Up With Effective Tech Transfer

Tech Transfer & Process Scale-up

How to Accelerate Process Scale-Up With Effective Tech Transfer

There's a need to accelerate pharma product development and process scale-up. Having an effective tech transfer strategy can help you.

Sofia Santos

Written by
Sofia Santos

Risk-Based Cleaning Validation: A Lifecycle Approach

Cleaning Validation

Risk-Based Cleaning Validation: A Lifecycle Approach

Explore the evolution of pharmaceutical cleaning validation from compliance-focused practices to a risk-based, lifecycle-driven approach.

Kenneth Pierce

Written by
Kenneth Pierce

Trending Topics With ValGenesis Customers

CSV and the Shift to CSA

CSA flips the paradigm of traditional CSV to "right-size" validation processes. Learn more about the benefits and principles of the CSA approach, which encourages critical thinking and automation.

Previously

Catalent's Journey of Continuous Improvement for CSV Excellence

Are You Aligned with FDA's Computer Software Assurance Methodology?

Cleaning Validation

Learn how digitization offers a consistent way to carry out cleaning validation lifecycle activities, ensuring your methods and procedures are risk-based and rooted in scientific evidence.

Previously

Change Impact Assessments in ValGenesis iClean™: A Framework for Consistency

Unlocking Operational Capacity with Fully Digitalized Cleaning Validation

Pharma 4.0

Waves of new technology and thinking — IoT, AR, cloud, Agile — are transforming the very foundation of validation processes. Learn how to leverage them in a Pharma 4.0 world.

High-quality Content Straight to Your Inbox!

Join our newsletter to receive updates on the latest news and industry-related content tailored to your preferences.